Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Proteins ; 85(7): 1190-1211, 2017 07.
Article in English | MEDLINE | ID: mdl-28378917

ABSTRACT

Triosephosphate isomerase (TIM) is a ubiquitous enzyme, which appeared early in evolution. TIM is responsible for obtaining net ATP from glycolysis and producing an extra pyruvate molecule for each glucose molecule, under aerobic and anaerobic conditions. It is placed in a metabolic crossroad that allows a quick balance of the triose phosphate aldolase produced by glycolysis, and is also linked to lipid metabolism through the alternation of glycerol-3-phosphate and the pentose cycle. TIM is one of the most studied enzymes with more than 199 structures deposited in the PDB. The interest for this enzyme stems from the fact that it is involved in glycolysis, but also in aging, human diseases and metabolism. TIM has been a target in the search for chemical compounds against infectious diseases and is a model to study catalytic features. Until February 2017, 62% of all residues of the protein have been studied by mutagenesis and/or using other approaches. Here, we present a detailed and comprehensive recompilation of the reported effects on TIM catalysis, stability, druggability and human disease produced by each of the amino acids studied, contributing to a better understanding of the properties of this fundamental protein. The information reviewed here shows that the role of the noncatalytic residues depend on their molecular context, the delicate balance between the short and long-range interactions in concerted action determining the properties of the protein. Each protein should be regarded as a unique entity that has evolved to be functional in the organism to which it belongs. Proteins 2017; 85:1190-1211. © 2017 Wiley Periodicals, Inc.


Subject(s)
Enzyme Inhibitors/chemistry , Triose-Phosphate Isomerase/chemistry , Amino Acid Sequence , Biocatalysis , Catalytic Domain , Enzyme Stability , Humans , Kinetics , Models, Molecular , Mutagenesis, Site-Directed , Protein Binding , Protein Interaction Domains and Motifs , Protein Structure, Secondary , Sequence Alignment , Sequence Homology, Amino Acid , Structure-Activity Relationship , Substrate Specificity , Triose-Phosphate Isomerase/antagonists & inhibitors , Triose-Phosphate Isomerase/genetics , Triose-Phosphate Isomerase/metabolism
2.
J Pharmacol Exp Ther ; 361(2): 292-302, 2017 05.
Article in English | MEDLINE | ID: mdl-28209723

ABSTRACT

Background: Mitochondrion is an important metabolic and energetic organelle that regulates several cellular processes. Mitochondrial dysfunction has been related to liver diseases including hepatocellular carcinoma. As a result, the energetic demand is not properly supplied and mitochondrial morphologic changes have been observed, resulting in an altered metabolism. We previously demonstrated the chemopreventive effect of the hepatoprotector IFC-305. Aim: In this work we aimed to evaluate the functional, metabolic, and dynamic mitochondrial alterations in the sequential model of cirrhosis-hepatocellular carcinoma induced by diethylnitrosamine in rats and the possible beneficial effect of IFC-305. Methods: Experimental groups of rats were formed to induce cirrhosis-hepatocellular carcinoma and to assess the IFC-305 effect during cancer development and progression through the evaluation of functional, metabolic, and dynamic mitochondrial parameters. Results: In this experimental model, dysfunctional mitochondria were observed and suspension of the diethylnitrosamine treatment was not enough to restore them. Administration of IFC-305 maintained and restored the mitochondrial function and regulated parameters implicated in metabolism as well as the mitochondrial dynamics modified by diethylnitrosamine intoxication. Conclusion: This study supports IFC-305 as a potential hepatocellular carcinoma treatment or as an adjuvant in chemotherapy.


Subject(s)
Adenosine/analogs & derivatives , Anticarcinogenic Agents/therapeutic use , Carcinoma, Hepatocellular/prevention & control , Liver Cirrhosis, Experimental/prevention & control , Liver Neoplasms, Experimental/prevention & control , Mitochondria, Liver/drug effects , Adenosine/pharmacology , Adenosine/therapeutic use , Adenosine Triphosphate/biosynthesis , Animals , Anticarcinogenic Agents/pharmacology , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/pathology , Electron Transport Complex I/metabolism , Liver Cirrhosis, Experimental/metabolism , Liver Cirrhosis, Experimental/pathology , Liver Neoplasms, Experimental/metabolism , Liver Neoplasms, Experimental/pathology , Male , Membrane Potential, Mitochondrial , Mitochondria, Liver/metabolism , Rats, Wistar
3.
Eur J Med Chem ; 100: 246-56, 2015 Jul 15.
Article in English | MEDLINE | ID: mdl-26094151

ABSTRACT

The neglected disease American trypanosomiasis is one of the major health problems in Latin America. Triosephosphate isomerase from Trypanosoma cruzi (TcTIM), the etiologic agent of this disease, has been proposed as a druggable target. Some bis-benzothiazoles have been described as irreversible inhibitors of this enzyme. On the other hand, new bioactive furane-containing thiazoles have been described as excellent in vivo anti-T. cruzi agents. This encouraged us to design and develop new bis-thiazoles with potential use as drugs for American trypanosomiasis. The bis-thiazol 5, 3,3'-allyl-2,2'-bis[3-(2-furyl)-2-propenylidenehydrazono]-2,2',3,3'-tetrahydro-4,4'-bisthiazole, showed the best in vitro anti-T. cruzi profile with a higher selectivity index than the reference drugs Nifurtimox and Benznidazole against amastigote form of the parasite. This derivative displayed marginal activity against TcTIM however the bis-thiazol 14, 3-allyl-2-[3-(2-furyl)-2-propenylidenehydrazono]-3'-phenyl-2'-(3-phenyl-2-propenylidenehydrazono]-2,2',3,3'-tetrahydro-4,4'-bisthiazole, was an excellent inhibitor of the enzyme of the parasite. The absence of both in vitro mutagenic and in vivo toxicity effects, together with the activity of bis-thiazol 5in vivo, suggests that this compound is a promising anti-T. cruzi agent surpassing the "hit-to-lead" stage in the drug development process.


Subject(s)
Enzyme Inhibitors/pharmacology , Thiazoles/pharmacology , Triose-Phosphate Isomerase/antagonists & inhibitors , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Trypanosoma cruzi/enzymology , Animals , Cell Line , Dose-Response Relationship, Drug , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/chemistry , Hydrophobic and Hydrophilic Interactions , Macrophages , Mice , Molecular Structure , Parasitic Sensitivity Tests , Structure-Activity Relationship , Thiazoles/chemical synthesis , Thiazoles/chemistry , Triose-Phosphate Isomerase/metabolism , Trypanocidal Agents/chemical synthesis , Trypanocidal Agents/chemistry
4.
Insect Biochem Mol Biol ; 41(6): 400-9, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21396445

ABSTRACT

Triosephosphate isomerase (TIM) is an enzyme with a role in glycolysis and gluconeogenesis by catalyzing the interconversion between glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. This enzyme has been used as a target in endoparasite drug development. In this work we cloned, expressed, purified and studied kinetic and structural characteristics of TIM from tick embryos, Rhipicephalus (Boophilus) microplus (BmTIM). The Km and Vmax of the recombinant BmTIM with glyceraldehyde 3-phosphate as substrate, were 0.47 mM and 6031 µmol min⁻¹ mg protein⁻¹, respectively. The resolution of the diffracted crystal was estimated to be 2.4 Å and the overall data showed that BmTIM is similar to other reported dimeric TIMs. However, we found that, in comparison to other TIMs, BmTIM has the highest content of cysteine residues (nine cysteine residues per monomer). Only two cysteines could make disulfide bonds in monomers of BmTIM. Furthermore, BmTIM was highly sensitive to the action of the thiol reagents dithionitrobenzoic acid and methyl methane thiosulfonate, suggesting that there are five cysteines exposed in each dimer and that these residues could be employed in the development of species-specific inhibitors.


Subject(s)
Embryo, Nonmammalian/enzymology , Recombinant Proteins/metabolism , Rhipicephalus/enzymology , Triose-Phosphate Isomerase/metabolism , Zygote/enzymology , Amino Acid Sequence , Animals , Catalysis , Cloning, Molecular , Crystallography, X-Ray , Cysteine/chemistry , Cysteine/metabolism , Dihydroxyacetone Phosphate/metabolism , Dimerization , Escherichia coli , Glyceraldehyde 3-Phosphate/metabolism , Humans , Kinetics , Models, Molecular , Molecular Sequence Data , Protein Conformation/drug effects , Recombinant Proteins/genetics , Rhipicephalus/embryology , Sequence Alignment , Sulfhydryl Reagents/pharmacology , Triose-Phosphate Isomerase/antagonists & inhibitors , Triose-Phosphate Isomerase/genetics , Triose-Phosphate Isomerase/isolation & purification
5.
J Bioenerg Biomembr ; 40(6): 561-8, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19139978

ABSTRACT

Although the capacity of isolated beta-subunits of the ATP synthase/ATPase to perform catalysis has been extensively studied, the results have not conclusively shown that the subunits are catalytically active. Since soluble F(1) of mitochondrial H(+)-ATPase can bind inorganic pyrophosphate (PP(i)) and synthesize PP(i) from medium phosphate, we examined if purified His-tagged beta-subunits from Thermophilic bacillus PS3 can hydrolyze PP(i). The difference spectra in the near UV CD of beta-subunits with and without PP(i) show that PP(i) binds to the subunits. Other studies show that beta-subunits hydrolyze [(32)P] PP(i) through a Mg(2+)-dependent process with an optimal pH of 8.3. Free Mg(2+) is required for maximal hydrolytic rates. The Km for PP(i) is 75 microM and the Vmax is 800 pmol/min/mg. ATP is a weak inhibitor of the reaction, it diminishes the Vmax and increases the Km for PP(i). Thus, isolated beta-subunits are catalytically competent with PP(i) as substrate; apparently, the assembly of beta-subunits into the ATPase complex changes substrate specificity, and leads to an increase in catalytic rates.


Subject(s)
ATP Synthetase Complexes/chemistry , ATP Synthetase Complexes/metabolism , Archaea/enzymology , Bacterial Proteins/chemistry , ATP Synthetase Complexes/isolation & purification , Catalysis , Enzyme Activation , Enzyme Stability , Hydrolysis , Solubility
6.
Biochemistry ; 42(11): 3311-8, 2003 Mar 25.
Article in English | MEDLINE | ID: mdl-12641463

ABSTRACT

Homodimeric triosephosphate isomerases from Trypanosoma cruzi (TcTIM) and Trypanosoma brucei (TbTIM) have markedly similar catalytic properties and 3-D structures; their overall amino acid sequence identity is 68% and 85% in their interface residues. Nonetheless, active dimer formation from guanidinium chloride unfolded monomers is faster and more efficient in TcTIM than in TbTIM. The enzymes thus provide a unique opportunity for exploring the factors that control the formation of active dimers. The kinetics of reactivation at different protein concentrations showed that the process involved three reactions: monomer folding, association of folded monomers, and a transition from inactive to active dimers. The rate constants of the reactions indicated that, at relatively low protein concentrations, the rate-limiting step of reactivation was the association reaction; at high protein concentrations the transition of inactive to active dimers was rate limiting. The rates of the latter two reactions were higher in TcTIM than in TbTIM. Studies with a mutant of TcTIM that had the interface residues of TbTIM showed that the association rate constant was similar to that of TbTIM. However, the rate of the transition from inactive to active dimers was close to that of TcTIM; thus, this transition depends on the noninterfacial portion of the enzymes. When unfolded monomers of TcTIM and TbTIM were allowed to reactivate together, TcTIM, the hybrid, and TbTIM were formed in a proportion of 1:0.9:0.2. This distribution suggests that, in the hybrid, the characteristics of the TcTIM monomers influence the properties of TbTIM monomers.


Subject(s)
Triose-Phosphate Isomerase/metabolism , Animals , Base Sequence , Circular Dichroism , DNA Primers , Dimerization , Enzyme Activation , Kinetics , Mutagenesis , Protein Denaturation , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Spectrometry, Fluorescence , Triose-Phosphate Isomerase/chemistry , Trypanosoma brucei brucei/enzymology , Trypanosoma cruzi/enzymology
7.
Proteins ; 48(3): 580-90, 2002 Aug 15.
Article in English | MEDLINE | ID: mdl-12112681

ABSTRACT

The susceptibility to subtilisin of homodimeric triosephosphate isomerase from Trypanosoma brucei (TbTIM) and Trypanosoma cruzi (TcTIM) was studied. Their amino sequence and 3D structure are markedly similar. In 36 h of incubation at a molar ratio of 4 TIM per subtilisin, TcTIM underwent extensive hydrolysis, loss of activity, and large structural alterations. Under the same conditions, only about 50% of the monomers of TbTIM were cleaved in two sites. The higher sensitivity of TcTIM to subtilisin is probably due to a higher intrinsic flexibility. We isolated and characterized TbTIM that had been exposed to subtilisin. It exhibited the molecular mass of the dimer, albeit it was formed by one intact and one nicked monomer. Its k(cat) with glyceraldehyde 3-phosphate was half that of native TbTIM, with no change in K(m). The intrinsic fluorescence of nicked TbTIM was red-shifted by 5 nm. The association between subunits was not affected. The TbTIM data suggest that there are structural differences in the two monomers or that alterations of one subunit change the characteristics of the other subunit. In comparison to the action of subtilisin on TIMs from other species, the trypanosomal enzymes appear to be unique.


Subject(s)
Triose-Phosphate Isomerase/metabolism , Trypanosoma brucei brucei/enzymology , Trypanosoma cruzi/enzymology , Amino Acid Sequence , Animals , Electrophoresis , Enzyme Stability , Hydrolysis , Kinetics , Molecular Sequence Data , Molecular Weight , Sequence Alignment , Subtilisin/metabolism , Triose-Phosphate Isomerase/chemistry , Trypanosoma brucei brucei/pathogenicity , Trypanosoma cruzi/pathogenicity
SELECTION OF CITATIONS
SEARCH DETAIL
...